Longevity risk debate: Particpants
Euromoney Limited, Registered in England & Wales, Company number 15236090
4 Bouverie Street, London, EC4Y 8AX
Copyright © Euromoney Limited 2024
Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Longevity risk debate: Particpants

Longevity risk debate: How pension schemes cope with an ageing population


Paul Kitson (PK) is a senior consultant at Watson Wyatt. He is chairman of its settlement consulting process group, which provides specialist advice on pension scheme risk mitigation transactions such as buy-out and mortality swaps. Paul has been lead adviser on a number of large pension scheme risk mitigation projects, advising on schemes from £50 million up to multi-billions in size. He is also a member of Watson Wyatt’s mortality specialist knowledge team.

Daniel Ryan (DR) is a senior consultant at Watson Wyatt. Over the past five years he has led a multi-disciplinary research group into understanding current mortality experience and estimating future longevity for the benefit of major UK insurers and reinsurers. He is a leading advocate of the use of patient medical databases and medical expert opinion to support and develop a disease-based approach to modelling mortality.

Andrew Reid (AR) is a director in the UK team of Credit Suisse’s life finance group. The group trades and structures products related to mortality risk. Andrew joined Credit Suisse in 2008, after 17 years at Watson Wyatt, latterly as head of corporate consulting in its pensions consultancy practice.

Gift this article